Email this article CITOTOXICITY OF INDIUM-111-LABELED AUTOLOGOUS WBC
- Authors: Luneva K.A.1,2, Ternovskaya K.E.1, Klement’eva O.E.1, Lunev A.S.1
-
Affiliations:
- A.I. Burnasyan Federal Medical Biophysical Center
- K.I. Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology
- Issue: No 1 (2019)
- Pages: 18-22
- Section: Articles
- Published: 28.02.2019
- URL: https://vestnik.nvsu.ru/0869-7922/article/view/641132
- DOI: https://doi.org/10.36946/0869-7922-2019-1-18-22
- ID: 641132
Cite item
Full Text
Abstract
The radiopharmaceutical precursor «Oxind, 111In» is a complex compound for labeling autologous leukocytes of human blood and their subsequent introduction for non-specific visualization and localization of inflammation foci of different nature by single-photon emission computed tomography (SPECT). The cytotoxic effect of lyophilisate for preparation of radiopharmaceutical preparation «Oxind, 111In» and its radiopharmaceutical precursor on rabbit blood leukocytes has been investigated. In the course of studies of the cytotoxicity of the lyophilisate for the preparation of a radiopharmaceutical precursor with successively increasing concentrations of the main substance, 8-hydroxyquinoline, the permissible concentrations have been determined and the absolutely cytotoxic concentration was achieved.
In the study of the cytotoxic effect of the precursor of radiopharmaceutical on two dosages that differ by 10 times in volume activities (MBq / ml), the absence of cytotoxic effects has been confirmed.
About the authors
K. A. Luneva
A.I. Burnasyan Federal Medical Biophysical Center;K.I. Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology
Author for correspondence.
Email: christfmbc@gmail.com
Lunyova Kristina Andreevna
123098, Moscow
Russian FederationK. E. Ternovskaya
A.I. Burnasyan Federal Medical Biophysical Center
Email: violet_mak@mail.ru
Ternovskaya Kristina Eduardovna
123098, Moscow
Russian FederationO. E. Klement’eva
A.I. Burnasyan Federal Medical Biophysical Center
Email: klementyeva.olga@gmail.com
Klementyeva Olga Evgenyevna
123098, Moscow
Russian FederationA. S. Lunev
A.I. Burnasyan Federal Medical Biophysical Center
Email: mr.alekslunev@gmail.com
Lunev Alexander Sergeevich
123098, Moscow
Russian FederationReferences
- Narkevich B.Ya., Kostylev V.A. Physical basis of nuclear medicine. Textbook. Moscow, АМF-Press, 2001 (in Russian).
- Davina K. Hughes Nuclear Medicine and Infection Detection: The Relative Effectiveness of Imaging with 111InOxine–, 99mTc-HMPAO–, and 99mTcStannous Fluoride Colloid–Labeled Leukocytes and with 67Ga-Citrate. J. Nucl. Med. Technol. Vol. 31, 20
- Datz F.L., Thorne D.A. Effect of chronicity of infection on the sensitivity of the In-111-labeled leukocyte scan. Am. J. Roentgenol. Vol. 147, 1986.
- Datz, F.L. Indium-111-labeled leukocytes for the detection of infection: current status. Semin. Nucl. Med. Vol. 24, 1994.
- Mc Afee J.G., Thakur M.L. Survey of radioactive agents for the in vitro labeling of phagocytic leucocytes. I Soluble agents. II Particles. J. Nucl. Med. Vol. 17 (6), 1976.
- Peters A.M., Osman S., Henderson B.L. et al. Clinical experience with 99mTc-hexamethylpropilene-amineoxime for labeling leucocytes and imaging inflammation. Lancet. Vol. 198, 19
- State Standard 33044-2014 by 01.08.20 Good Laboratory Practice. Interstate Council of standardization, metrology and certification. Moscow, 2015 (in Russian).
- Euthanasia of experimental animals. Guidelines. Moscow; 1985 (in Russian).
- European Convention for the Protection Vertebrate Animals Use for Experimental and Other Scientifi Purposes. European Treaty Series No. 1 March 18 19 Strasbourg, 1986.
- M. Roca, E. F. J. de Vries, F. Jamar, O. Israel, A. Signore. Guidelines for the labelling of leucocytes with 111 In-oxine. Eur J Nucl Med Mol Imaging. 2010; 37:835–8doi: 10.1007/s00259-0101393-5.
Supplementary files
